Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

2026-04-01
WESTBROOK, Maine, April 01, 2026--IDEXX Cancer Dx Panel with canine lymphoma detection helps clinicians investigate sooner and plan next steps with confidence.

IDEXX Launches Cancer Dx Panel In UK For Early Canine Lymphoma Detection, Detecting Signals Up To Eight Months Before Clinical Signs

2026-04-01

Stifel Maintains Buy on IDEXX Laboratories, Lowers Price Target to $675

2026-03-31
Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the price target from $775 to $675.

IDEXX LABORATORIES INC (NASDAQ:IDXX) Passes the Caviar Cruise Quality Stock Screen

2026-03-31
IDEXX Laboratories exemplifies quality investing with durable competitive advantages, high profitability, and strong financial health, making it a standout long-term growth candidate.

Top Stock Reports for Roche, AT&T & Amgen

2026-03-30
Roche's strong drug growth is offsetting legacy declines, while strategic deals aim to reshape its portfolio amid biosimilar pressure and FX headwinds.

Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More

2026-03-30
Key market opportunities in companion animal health include advancements in therapeutics, diagnostics, and precision-driven veterinary medicines, adoption of AI in diagnostics, and growing demand for preventive care due to zoonotic disease awareness Companion Animal Health Market Companion Animal Health Market Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Companion Animal Health Market Size, Share & Trends Analysis Report by Animal, Product, Distribution Channel, End-use, Region, and Segment F

Back-up care benefits at work go beyond kids, aging parents as more employers pay for pets

2026-03-29
Companies are expanding employee benefits to cover a wide variety of caregiving needs, including back-up care for children, aging parents, and pets.

IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors

2026-03-27
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors

Wall Street Lunch: Big Trades Ahead Of Announcements Raise Questions

2026-03-24
Trading this week has underscored just how sensitive markets are to any hint of an endgame in the Iran conflict — verified or not.

Pet Services Jump 5.1% as Vet Visits Fall for 16th Straight Quarter

2026-03-23
Rising pet-care costs and declining visits highlight shift toward higher-value treatments supporting animal health companies' earnings.